Literature DB >> 30811892

OPTN/SRTR 2017 Annual Data Report: Lung.

M Valapour1,2, C J Lehr2, M A Skeans1, J M Smith1,3, K Uccellini4,5, R Lehman4,5, A Robinson4,5, A K Israni1,6,7, J J Snyder1,6, B L Kasiske1,7.   

Abstract

Each year since 2012, the number of lung transplants has increased, reflecting an increase in the number of donors, improved use of recovered organs, and more candidates being listed for transplant. However, the need for organs continues to outpace available donors. Despite an increase of 126 donors in 2017, 1360 candidates remained on the waiting list at the end of the year, and 326 patients died or became too sick to undergo transplant. Approximately 14,000 individuals were living with a lung transplant in 2017; 9492 were aged 50 years or older, 4075 were aged 18-49 years, and 408 were aged younger than 18 years. .

Entities:  

Keywords:  End-stage lung disease; LAS; lung allocation score; lung transplant; organ allocation; revised lung allocation score; transplant outcomes

Mesh:

Year:  2019        PMID: 30811892     DOI: 10.1111/ajt.15279

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  26 in total

1.  Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.

Authors:  Jared P Beller; Matthew R Byler; Dustin T Money; William Z Chancellor; Aimee Zhang; Yunge Zhao; Mark H Stoler; Adishesh K Narahari; Alexander Shannon; J Hunter Mehaffey; Curtis G Tribble; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  J Heart Lung Transplant       Date:  2019-09-18       Impact factor: 10.247

2.  Expanding the pool: the use of hepatitis C RNA positive organs in lung transplantation.

Authors:  Ernest G Chan; Patrick G Chan; Pablo G Sanchez
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

3.  Expanding the donor pool for lung transplantation using HCV-positive donors.

Authors:  Hrishikesh S Kulkarni; Kevin M Korenblat; Daniel Kreisel
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Predictors of Older Donor Lung Use: Are We Too Good at Saying No?

Authors:  Ashley Y Choi; Oliver K Jawitz; Vignesh Raman; Samantha E Halpern; John C Haney; Jacob A Klapper; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2020-05-31       Impact factor: 4.330

5.  Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.

Authors:  Yaron D Barac; Mike S Mulvihill; Oliver Jawitz; Jacob Klapper; John Haney; Mani Daneshmand; Basil Nasir; Dongfeng Chen; Carmelo A Milano; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2020-04-03       Impact factor: 4.330

Review 6.  Autoantibodies in lung transplantation.

Authors:  Angara Sureshbabu; Timothy Fleming; Thalachallour Mohanakumar
Journal:  Transpl Int       Date:  2019-08-27       Impact factor: 3.782

Review 7.  Dissemination and Implementation Science in Cardiothoracic Surgery: A Review and Case Study.

Authors:  Brendan T Heiden; Emmanuel Tetteh; Keenan J Robbins; Rachel G Tabak; Ruben G Nava; Gary F Marklin; Daniel Kreisel; Bryan F Meyers; Benjamin D Kozower; Virginia R McKay; Varun Puri
Journal:  Ann Thorac Surg       Date:  2021-09-06       Impact factor: 5.102

8.  Is perfusate exchange during ex vivo lung perfusion beneficial?

Authors:  Christina C Kao; Amit D Parulekar
Journal:  Ann Transl Med       Date:  2020-02

9.  Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study.

Authors:  Wayne M Tsuang; Susana Arrigain; Rocio Lopez; Megan Snair; Marie Budev; Jesse D Schold
Journal:  Transplantation       Date:  2020-11       Impact factor: 5.385

10.  The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.

Authors:  Ann E Woolley; Laura M Piechura; Hilary J Goldberg; Steve K Singh; Antonio Coppolino; Lindsey R Baden; Hari R Mallidi
Journal:  Ann Cardiothorac Surg       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.